INS and neoplasm: Considering that most malignant INS are diagnosed when already metastatic after a long period of latency, it is possible that initially low functional activity/insulin production from tumor cells only becomes clinically significant at later stages of the disease with a higher tumor burden, causing early misdiagnosis and/or delay the accurate diagnosis of malignant INS [1,87,88].